In particular, we focused on the functional expression of NCX in cells located within the migrating front, employing different GBM cell lines, i.e., U251 and U87, and a primary human glioblastoma culture enriched in stem cells (GSCs). The gene discussed is TLX2; the disease is glioblastoma.